[HTML][HTML] Glucose sensing in L cells: a primary cell study
F Reimann, AM Habib, G Tolhurst, HE Parker… - Cell metabolism, 2008 - cell.com
Summary Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …
Glucose Sensing in L Cells: A Primary Cell Study
F Reimann, AM Habib, G Tolhurst, HE Parker… - Cell Metabolism, 2008 - infona.pl
Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin secretion and
improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are clinically …
improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are clinically …
[引用][C] Glucose Sensing in L Cells: A Primary Cell Study
F Reimann, AM Habib, G Tolhurst, HE Parker… - Cell Metabolism, 2008 - cir.nii.ac.jp
Glucose Sensing in L Cells: A Primary Cell Study | CiNii Research CiNii 国立情報学研究所 学術
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
[HTML][HTML] Glucose Sensing in L Cells: A Primary Cell Study
F Reimann, AM Habib, G Tolhurst, HE Parker… - Cell Metabolism, 2008 - Elsevier
Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin secretion and
improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are clinically …
improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are clinically …
Glucose sensing in L cells: a primary cell study
F Reimann, AM Habib, G Tolhurst… - Cell …, 2008 - pubmed.ncbi.nlm.nih.gov
Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin secretion and
improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are clinically …
improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are clinically …
[PDF][PDF] Glucose Sensing in L Cells: A Primary Cell Study
F Reimann, AM Habib, G Tolhurst, HE Parker… - Cell …, 2008 - cyberleninka.org
SUMMARY Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …
[HTML][HTML] Glucose Sensing in L Cells: A Primary Cell Study
F Reimann, AM Habib, G Tolhurst, HE Parker… - Cell …, 2008 - ncbi.nlm.nih.gov
Summary Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …
[PDF][PDF] Glucose Sensing in L Cells: A Primary Cell Study
F Reimann, AM Habib, G Tolhurst, HE Parker… - Cell Metabolism, 2008 - core.ac.uk
SUMMARY Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …
Glucose sensing in L cells: a primary cell study.
F Reimann, AM Habib, G Tolhurst, HE Parker… - Cell …, 2008 - europepmc.org
Summary Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …
[PDF][PDF] Glucose Sensing in L Cells: A Primary Cell Study
F Reimann, AM Habib, G Tolhurst, HE Parker… - 2008 - researchgate.net
Summary Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …
secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are …